United States · FDA National Drug Code directory
OPDUALAG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-7125_7c285448-d5b9-4eca-b117-0d791b1b4de3
- Product NDC
- 0003-7125
- Form
- INJECTION
- Composition / generic term
- nivolumab and relatlimab-rmbw
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20220318
- Source listing expiry
- 20271231
Source-listed ingredients
- NIVOLUMAB — 12 mg/mL
- RELATLIMAB — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE · 0003-7125-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →